| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246336C P28 GANK antibody used for liver cancer identification and diagnosis and its preparation method |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246334C Antibodies capable of detecting beer spoilage lactic acid bacteria and detecting method using same, and reagent kit with same |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/21/2006 | US7015316 persephin is a member of the GDNF-Neurturin family of growth factors; Glial-derived neurotrophic factor (GDNF); promotes survival of mesencephalic neuronal cells; nucleic acids of given sequences |
| 03/21/2006 | US7015312 Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7015048 Methods and kits for diagnosing or monitoring synovial or osteoarticular disease, comprising the use of a specific marker for synovial tissue degradation |
| 03/21/2006 | US7015034 Materials and procedures for the purification of cells |
| 03/21/2006 | US7015016 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7015008 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 03/21/2006 | US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 03/21/2006 | US7015004 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 03/21/2006 | US7014855 inducing an immune response against a peptide component of an amyloid deposit; active administration of an immunogen or passive administration of an antibody or an active fragment or derivative of the antibody; Alzheimer's disease |
| 03/21/2006 | US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/16/2006 | WO2006029369A2 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 03/16/2006 | WO2006029275A2 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | WO2006029224A2 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | WO2006029219A2 Human monoclonal anti-ctla4 antibodies in cancer treatment |
| 03/16/2006 | WO2006029183A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | WO2006029089A2 Tetrahydrocannabinoid- protein conjugates for the production of antibodies for the detection of tεtrahydrocannabinoid components in saliva |
| 03/16/2006 | WO2006029045A2 Endothelial cell specific antibodies and uses thereof |
| 03/16/2006 | WO2006029005A2 Promoter substitution for immunoglobulin therapy |
| 03/16/2006 | WO2006028655A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/16/2006 | WO2006028576A2 Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor |
| 03/16/2006 | WO2006028429A2 Peptides for targeting the prostate specific membrane antigen |
| 03/16/2006 | WO2006028197A1 Anti-a33 antibody |
| 03/16/2006 | WO2006014477A9 HIGH AFFINITY ANTI-TNF-α ANTIBODIES AND METHOD |
| 03/16/2006 | WO2005121175A9 Env polypeptide complexes and methods of use |
| 03/16/2006 | WO2005121168A3 Heparin binding peptide |
| 03/16/2006 | WO2005118813A3 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 03/16/2006 | WO2005116645A3 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 03/16/2006 | WO2005115453A3 Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies |
| 03/16/2006 | WO2005113003A3 Method for augmenting b cell depletion |
| 03/16/2006 | WO2005105847A3 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof |
| 03/16/2006 | WO2005105845A3 Phep, an amino acid permease of staphylococcus aureus |
| 03/16/2006 | WO2005097160A3 Modulation of nkg2d |
| 03/16/2006 | WO2005084179A3 Improved method for preparing conjugates of proteins and chelating agents |
| 03/16/2006 | WO2005077007A3 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 03/16/2006 | WO2005063817A3 Methods for identifying functional antibodies |
| 03/16/2006 | WO2005063815A3 Fcϝ receptor-binding polypeptide variants and methods related thereto |
| 03/16/2006 | WO2005060998A3 Methods of modulating cytokine activity; related reagents |
| 03/16/2006 | WO2005012337A3 Antigenic peptides of sars coronavirus and uses thereof |
| 03/16/2006 | US20060059575 Method for preparing monoclonal antibody |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058511 Method for stabilizing protein solution preparation |
| 03/16/2006 | US20060058507 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2006 | US20060057695 GANP protein |
| 03/16/2006 | US20060057679 RAGE protein derivatives |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057636 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/16/2006 | US20060057632 Artificial antibody library with super-repertory |
| 03/16/2006 | US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/16/2006 | US20060057150 Compositions against chicken coccidiosis |
| 03/16/2006 | US20060057149 Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057145 Methods to prevent tumor recurrence by blockade of tgf-beta |
| 03/16/2006 | US20060057141 Ovarian carcinoma polypeptides having a specific amino acid sequence, its fusion proteins and polynucleotides encoding them; cancer vaccines |
| 03/16/2006 | US20060057140 Anticoagulant agents useful in treatment of thrombosis |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057138 Protein that includes a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence; the protein ligand binds to Tie1 ectodomain, a receptor tyrosine kinase protein that includes a transmembrane domain; use in modulating angiogenesis |
| 03/16/2006 | US20060057136 Immunotherapy of B-Cell malignancies using anti-CD22 antibodies |
| 03/16/2006 | US20060057135 Mucosal vascular addressins and uses thereof |
| 03/16/2006 | US20060057134 Antibody against antibacterial peptide and utiliazation thereof |
| 03/16/2006 | US20060057103 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents |
| 03/16/2006 | US20060057099 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/16/2006 | US20060057062 Compositions and methods useful in pretargeted imaging |
| 03/16/2006 | CA2579802A1 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 03/16/2006 | CA2579102A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/16/2006 | CA2577828A1 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | CA2577823A1 Methods of using death receptor ligands and cd20 antibodies |
| 03/16/2006 | CA2577405A1 Anti-fc-gamma riib receptor antibody and uses therefor |
| 03/16/2006 | CA2577082A1 Heteromultimeric molecules |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634951A1 Novel protein |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1634077A2 Micropositioning cells for tissue engineering |
| 03/15/2006 | EP1633853A2 Severe acute respiratory syndrome dna vaccine compositions and methods of use |
| 03/15/2006 | EP1633850A2 Ovr115 ANTIBODY COMPOSITION AND METHODS OF USE |
| 03/15/2006 | EP1633788A2 Monoclonal antibodies specific for buprenorphine and metabolites thereof |
| 03/15/2006 | EP1633787A1 Methods for producing antibodies |
| 03/15/2006 | EP1633786A2 Methods of treating alzheimer s disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1633784A2 Ovr110 antibody compositions and methods of use |
| 03/15/2006 | EP1633778A1 Poly-gamma-glutamic acid conjugates for eliciting immune responses directed against bacilli |
| 03/15/2006 | EP1633775A2 Antigenic peptides of sars coronavirus and uses thereof |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633399A2 Recombinant antibodies and compositions and methods for making and using the same |
| 03/15/2006 | EP1633398A2 Preparation and application of anti-tumor bifunctional fusion proteins |
| 03/15/2006 | EP1633397A2 Anti-ghrelin fab antibodies |
| 03/15/2006 | EP1633396A1 Cd20 binding molecules |